Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page
Price
Target price
€22.79

€22.79

1.880%
0.52
1.880%
€28.00

€28.00

 
Latest predictions
-
23.09.20
buy
-
14.08.20
€28.00
14.08.20
buy
-
11.07.20
buy
€27.00
10.06.20
buy
€27.00
30.04.20
buy
Your prediction

Evotec AG Stock

Evotec AG gained 1.880% today.
The stock is one of the favorites of our community with 31 Buy predictions and 2 Sell predictions.
As a result the target price of €28.00 shows a positive potential of 22.861% compared to the current price of €22.79 for Evotec AG.

Pros and Cons of Evotec AG in the next few years

Pros
1
EBIT growth >5% per year expected
1
Revenue growth >5% per year expected
Cons
0
-

Comments

Buy Evotec AG

Buy Evotec AG

Published 26.01.20
Prediction Buy
Perf. (%) 25.493%
Target price
Change

Buy beendet

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Evotec AG Stock

Trading Evotec AG

Trading Evotec AG

New thread Forum

News

DGAP-News: EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON

DGAP-News: EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON

DGAP-News: EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK

DGAP-News: EVOTEC EXPANDS ITS PROPRIETARY PATIENT DATABASE INTO LIVER DISEASE WITH UNIQUE ACCESS TO QUOD BIOBANK

DGAP-News: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO GAUCHER DISEASE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO GAUCHER DISEASE

DGAP-News: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO GAUCHER DISEASE

DGAP-News: EVOTEC AND NOVO NORDISK FORM STRATEGIC ALLIANCE TO DEVELOP NOVEL THERAPIES FOR KIDNEY DISEASES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND NOVO NORDISK FORM STRATEGIC ALLIANCE TO DEVELOP NOVEL THERAPIES FOR KIDNEY DISEASES

DGAP-News: EVOTEC AND NOVO NORDISK FORM STRATEGIC ALLIANCE TO DEVELOP NOVEL THERAPIES FOR KIDNEY DISEASES

DGAP-News: EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES

DGAP-News: EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES

DGAP-News: EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT

DGAP-News: EVOTEC RECEIVES CARB-X FUNDING FOR RESOLUTE'S ANTIBIOTIC PROJECT

DGAP-News: EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020

DGAP-News: EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020

DGAP-News: EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY

DGAP-News: EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY

DGAP-News: JUST - EVOTEC BIOLOGICS TO PRODUCE MONOCLONAL ANTIBODY PRODUCTS AGAINST COVID-19 FOR THE DEPARTMENT OF DEFENSE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: JUST - EVOTEC BIOLOGICS TO PRODUCE MONOCLONAL ANTIBODY PRODUCTS AGAINST COVID-19 FOR THE DEPARTMENT OF DEFENSE

DGAP-News: JUST - EVOTEC BIOLOGICS TO PRODUCE MONOCLONAL ANTIBODY PRODUCTS AGAINST COVID-19 FOR THE DEPARTMENT OF DEFENSE

DGAP-News: EVOTEC ENTERS PARTNERSHIP WITH QUANTRO THERAPEUTICS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC ENTERS PARTNERSHIP WITH QUANTRO THERAPEUTICS

DGAP-News: EVOTEC ENTERS PARTNERSHIP WITH QUANTRO THERAPEUTICS

DGAP-News: EVOTEC INITIATES 'CAMPUS CURIE' IN TOULOUSE : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC INITIATES 'CAMPUS CURIE' IN TOULOUSE

DGAP-News: EVOTEC INITIATES 'CAMPUS CURIE' IN TOULOUSE

DGAP-News: EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS

DGAP-News: EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS

DGAP-News: EVOTEC SE VIRTUAL ANNUAL GENERAL MEETING 2020 APPROVES ALL PROPOSED AGENDA ITEMS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE VIRTUAL ANNUAL GENERAL MEETING 2020 APPROVES ALL PROPOSED AGENDA ITEMS

DGAP-News: EVOTEC SE VIRTUAL ANNUAL GENERAL MEETING 2020 APPROVES ALL PROPOSED AGENDA ITEMS

DGAP-News: JUST - EVOTEC BIOLOGICS PARTNERS WITH ABL ON DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: JUST - EVOTEC BIOLOGICS PARTNERS WITH ABL ON DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV

DGAP-News: JUST - EVOTEC BIOLOGICS PARTNERS WITH ABL ON DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV

DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA'): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA')

DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA')

DGAP-News: EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUND: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUND

DGAP-News: EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUND

DGAP-News: EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE

DGAP-News: EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE

DGAP-News: EVOTEC SE TO REPORT FIRST QUARTER 2020 RESULTS ON 14 MAY 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC SE TO REPORT FIRST QUARTER 2020 RESULTS ON 14 MAY 2020

DGAP-News: EVOTEC SE TO REPORT FIRST QUARTER 2020 RESULTS ON 14 MAY 2020

DGAP-News: JUST - EVOTEC BIOLOGICS TO COLLABORATE WITH OLOGY BIOSERVICES ON ANTIBODIES AGAINST CORONAVIRUS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: JUST - EVOTEC BIOLOGICS TO COLLABORATE WITH OLOGY BIOSERVICES ON ANTIBODIES AGAINST CORONAVIRUS

DGAP-News: JUST - EVOTEC BIOLOGICS TO COLLABORATE WITH OLOGY BIOSERVICES ON ANTIBODIES AGAINST CORONAVIRUS

DGAP-News: EVOTEC REGAINS GLOBAL RIGHTS TO BETA CELL REPLACEMENT THERAPY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC REGAINS GLOBAL RIGHTS TO BETA CELL REPLACEMENT THERAPY

DGAP-News: EVOTEC REGAINS GLOBAL RIGHTS TO BETA CELL REPLACEMENT THERAPY

DGAP-News: EVOTEC ENTERS NANOMEDICINE THROUGH STRATEGIC PARTNERSHIP WITH LEON-NANODRUGS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC ENTERS NANOMEDICINE THROUGH STRATEGIC PARTNERSHIP WITH LEON-NANODRUGS

DGAP-News: EVOTEC ENTERS NANOMEDICINE THROUGH STRATEGIC PARTNERSHIP WITH LEON-NANODRUGS

DGAP-News: EVOTEC AND TAKEDA ENTER INTO MULTI-YEAR GENE THERAPY RESEARCH ALLIANCE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND TAKEDA ENTER INTO MULTI-YEAR GENE THERAPY RESEARCH ALLIANCE

DGAP-News: EVOTEC AND TAKEDA ENTER INTO MULTI-YEAR GENE THERAPY RESEARCH ALLIANCE

DGAP-News: EVOTEC EXPANDS INTO GENE THERAPY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC EXPANDS INTO GENE THERAPY

DGAP-News: EVOTEC EXPANDS INTO GENE THERAPY

DGAP-News: EVOTEC EXPANDS ITS IPSC-BASED CELL THERAPY PLATFORM EVOCELLS THROUGH LICENSING AGREEMENT WITH PANCELLA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC EXPANDS ITS IPSC-BASED CELL THERAPY PLATFORM EVOCELLS THROUGH LICENSING AGREEMENT WITH PANCELLA

DGAP-News: EVOTEC EXPANDS ITS IPSC-BASED CELL THERAPY PLATFORM EVOCELLS THROUGH LICENSING AGREEMENT WITH PANCELLA

DGAP-News: EVOTEC AND ILDONG TO COLLABORATE WITH DEVELOPMENT PROJECTS ON INDIGO PLATFORM: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND ILDONG TO COLLABORATE WITH DEVELOPMENT PROJECTS ON INDIGO PLATFORM

DGAP-News: EVOTEC AND ILDONG TO COLLABORATE WITH DEVELOPMENT PROJECTS ON INDIGO PLATFORM